Nimotop

Active Ingredient(s): Nimodipine
FDA Approved: * December 28, 1988
Pharm Company: * BAYER PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nimotop Overview

Nimodipine (sold under the brandname Nimotop) is a calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm; this is now the main use of nimodipine. Contents 1 Medical use 1.1 Dosage 2 Contraindications 3 Side-effects 4 Pharmacokinetics 4.1 Absorption 4.2 Metabolism 4.3 Exc...

Read more Nimotop Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nimodipine

Recent Nimotop Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Nimodipine or a similar ingredient: (2 results)

• NIMODIPINE
• NYMALIZE Nimodipine